# Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development

> **NCT04956445** · — · UNKNOWN · sponsor: **Tulane University** · enrollment: 2000 (estimated)

## Conditions studied

- Covid19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04956445
- **Lead sponsor:** Tulane University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-17
- **Primary completion:** 2025-03
- **Final completion:** 2025-03
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2023-12-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04956445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04956445, "Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04956445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*